» Articles » PMID: 36836959

Effectiveness of a Single Chair Side Application of NovaMin [Calcium Sodium Phosphosilicate] in the Treatment of Dentine Hypersensitivity Following Ultrasonic Scaling-A Randomized Controlled Trial

Abstract

Dentinal hypersensitivity or cervical dentinal sensitivity is one of the commonest clinical problems. The aim of this randomized controlled trial was to evaluate the effectiveness of a single chair side application of 100% pure calcium sodium phosphosilicate (NovaMin) in reducing dentin hypersensitivity following ultrasonic scaling as evaluated on a visual analogue scale (VAS). The study included 50 subjects who were selected based on an evaluation of dentinal hypersensitivity on a VAS carried out using a metered air blast from a three-way syringe and divided into two groups ( = 25/group); i.e., the test group (Group A) received the NovaMin paste and the control group (Group B) received a placebo paste made from pumice. All the 50 subjects included in the study were had VAS scores of 3 or more. The NovaMin powder mixed with distilled water was applied. Dentinal hypersensitivity was reassessed immediately and after 1, 2 and 4 weeks after the procedure. Results showed that the percentage reduction of dentinal hypersensitivity following a single application of NovaMin in powder form was about 76.38% immediately, 67.72% one week postoperatively, 52.76% two weeks postoperatively and 26.78% four weeks postoperatively. It can be concluded from the results of the current clinical study demonstrated that a single chair side application of NovaMin in powder form has a significant and immediate reduction in dentinal hypersensitivity, which lasted nearly for four weeks.

Citing Articles

Advanced Materials for Oral Application (Volume 2).

Rusu L, Ardelean L Materials (Basel). 2025; 18(5).

PMID: 40077268 PMC: 11901160. DOI: 10.3390/ma18051042.


Importance of periodontal phenotype in periodontics and restorative dentistry: a systematic review.

Kumar P M, Nagate R, Chaturvedi S, Al-Ahmari M, A Al-Qarni M, Gokhale S BMC Oral Health. 2024; 24(1):41.

PMID: 38191372 PMC: 10773067. DOI: 10.1186/s12903-023-03777-3.


Role of YAP in Odontoblast Damage Repair in a Dentin Hypersensitivity Model.

Tong X, Wang Y, Zhang H, Liu P, Wang C, Liu H Int Dent J. 2024; 74(3):597-606.

PMID: 38184457 PMC: 11123538. DOI: 10.1016/j.identj.2023.11.003.


Evaluation of Propolis Hydrogel for the Treatment of Dentinal Sensitivity: A Clinical Study.

Alqahtani S, Nagate R, Al-Ahmari M, Magbol M, Gokhale S, Tikare S Gels. 2023; 9(6).

PMID: 37367153 PMC: 10298203. DOI: 10.3390/gels9060483.


Challenges of E-Learning: Behavioral Intention of Academicians to Use E-Learning during COVID-19 Crisis.

Khan M, Viswanath Reddy L, Khan J, Narapureddy B, Vaddamanu S, Hussain Alhamoudi F J Pers Med. 2023; 13(3).

PMID: 36983736 PMC: 10056789. DOI: 10.3390/jpm13030555.


References
1.
Hsu S, Alsafadi M, Vasconez C, Fares C, Craciun V, ONeill E . Qualitative Analysis of Remineralization Capabilities of Bioactive Glass (NovaMin) and Fluoride on Hydroxyapatite (HA) Discs: An In Vitro Study. Materials (Basel). 2021; 14(14). PMC: 8306171. DOI: 10.3390/ma14143813. View

2.
Bm S, P P, Sanghani N . Chair Side Application of NovaMin for the Treatment of Dentinal Hypersensitivity- A Novel Technique. J Clin Diagn Res. 2014; 8(10):ZC05-8. PMC: 4253255. DOI: 10.7860/JCDR/2014/8824.4947. View

3.
Rees J . The prevalence of dentine hypersensitivity in general dental practice in the UK. J Clin Periodontol. 2000; 27(11):860-5. DOI: 10.1034/j.1600-051x.2000.027011860.x. View

4.
Sauro S, Gandolfi M, Prati C, Mongiorgi R . Oxalate-containing phytocomplexes as dentine desensitisers: an in vitro study. Arch Oral Biol. 2006; 51(8):655-64. DOI: 10.1016/j.archoralbio.2006.02.010. View

5.
Que K, Guo B, Jia Z, Chen Z, Yang J, Gao P . A cross-sectional study: non-carious cervical lesions, cervical dentine hypersensitivity and related risk factors. J Oral Rehabil. 2012; 40(1):24-32. DOI: 10.1111/j.1365-2842.2012.02342.x. View